Progression of renal damage in glycogen storage disease type I is associated to hyperlipidemia: a multicenter prospective Italian study
Related Experiment Video
Updated: Apr 18, 2026

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Published on: November 21, 2025
Daniela Melis1, Mariarosaria Cozzolino2, Giorgia Minopoli2
1Welfare Department of Pediatrics, Azienda Ospedaliera Universitaria Federico II, Naples, Italy.
Abstract:
Angiotensin converting enzyme (ACE)-inhibitors decrease glomerular hyperfiltration but not microalbuminuria and proteinuria in glycogen storage disease type I. In the current study, we demonstrated that severe hyperlipidemia is associated with ACE-inhibitor ineffectiveness. We underline the importance of adequate metabolic control in glycogen storage disease type I. A combination therapy with ACE-inhibitors and lipid lowering drugs might be considered.
More Related Videos
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Related Concept Videos
Diabetic Nephropathy
Type II Diabetes II: Pathophysiology
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease I: Introduction
Diabetic Retinopathy
Hyperglycemia